DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 894 filers reported holding DANAHER CORPORATION in Q1 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $30,629,278 | +6.1% | 122,591 | +6.0% | 0.03% | +3.1% |
Q1 2024 | $28,873,294 | +22.8% | 115,622 | +13.7% | 0.03% | -27.3% |
Q4 2023 | $23,516,120 | -12.2% | 101,651 | -5.8% | 0.04% | +22.2% |
Q3 2023 | $26,768,858 | +18.8% | 107,895 | +14.9% | 0.04% | +20.0% |
Q2 2023 | $22,537,943 | -3.4% | 93,908 | +1.5% | 0.03% | -11.8% |
Q1 2023 | $23,329,273 | -0.8% | 92,562 | +4.4% | 0.03% | -2.9% |
Q4 2022 | $23,528,491 | +35.0% | 88,646 | +31.4% | 0.04% | +16.7% |
Q3 2022 | $17,430,000 | -3.4% | 67,484 | -5.2% | 0.03% | 0.0% |
Q2 2022 | $18,045,000 | +3.0% | 71,179 | +19.1% | 0.03% | +11.1% |
Q1 2022 | $17,526,000 | -15.3% | 59,750 | -5.0% | 0.03% | -18.2% |
Q4 2021 | $20,686,000 | +9.8% | 62,873 | +1.6% | 0.03% | 0.0% |
Q3 2021 | $18,833,000 | -1.2% | 61,861 | -12.9% | 0.03% | -2.9% |
Q2 2021 | $19,065,000 | +79.0% | 71,039 | +50.1% | 0.03% | +61.9% |
Q1 2021 | $10,653,000 | +14.5% | 47,331 | +13.0% | 0.02% | +5.0% |
Q4 2020 | $9,304,000 | +1.4% | 41,882 | -1.7% | 0.02% | -16.7% |
Q3 2020 | $9,174,000 | +40.3% | 42,603 | +15.2% | 0.02% | +26.3% |
Q2 2020 | $6,539,000 | +25.7% | 36,977 | -1.6% | 0.02% | +5.6% |
Q1 2020 | $5,201,000 | -12.6% | 37,573 | -3.1% | 0.02% | 0.0% |
Q4 2019 | $5,950,000 | +9.8% | 38,765 | +3.3% | 0.02% | 0.0% |
Q3 2019 | $5,420,000 | +5.0% | 37,529 | +3.9% | 0.02% | +5.9% |
Q2 2019 | $5,164,000 | +22.6% | 36,133 | +13.3% | 0.02% | +13.3% |
Q1 2019 | $4,211,000 | +33.0% | 31,900 | +3.3% | 0.02% | +15.4% |
Q4 2018 | $3,165,000 | -10.6% | 30,895 | -5.2% | 0.01% | 0.0% |
Q3 2018 | $3,541,000 | +14.8% | 32,585 | +4.3% | 0.01% | +8.3% |
Q2 2018 | $3,084,000 | +9.1% | 31,255 | +8.2% | 0.01% | 0.0% |
Q1 2018 | $2,827,000 | +11.3% | 28,875 | +5.6% | 0.01% | +9.1% |
Q4 2017 | $2,539,000 | +13.2% | 27,356 | +4.6% | 0.01% | +10.0% |
Q3 2017 | $2,243,000 | +13.0% | 26,147 | +11.2% | 0.01% | 0.0% |
Q2 2017 | $1,985,000 | +7.1% | 23,518 | +4.2% | 0.01% | 0.0% |
Q1 2017 | $1,854,000 | +37.8% | 22,572 | +18.4% | 0.01% | +25.0% |
Q4 2016 | $1,345,000 | -4.1% | 19,062 | +1.4% | 0.01% | -11.1% |
Q3 2016 | $1,403,000 | -10.9% | 18,790 | +20.6% | 0.01% | -18.2% |
Q2 2016 | $1,574,000 | +10.8% | 15,581 | +4.1% | 0.01% | 0.0% |
Q1 2016 | $1,420,000 | +4.6% | 14,965 | +2.4% | 0.01% | 0.0% |
Q4 2015 | $1,358,000 | +49.1% | 14,616 | +36.8% | 0.01% | +37.5% |
Q3 2015 | $911,000 | +3.2% | 10,688 | +3.6% | 0.01% | 0.0% |
Q2 2015 | $883,000 | +19.3% | 10,318 | +18.4% | 0.01% | +14.3% |
Q1 2015 | $740,000 | -6.7% | 8,717 | -5.8% | 0.01% | -12.5% |
Q4 2014 | $793,000 | +9.5% | 9,250 | -2.9% | 0.01% | 0.0% |
Q3 2014 | $724,000 | +11.6% | 9,526 | +15.5% | 0.01% | 0.0% |
Q2 2014 | $649,000 | +13.9% | 8,246 | +8.5% | 0.01% | -11.1% |
Q1 2014 | $570,000 | -3.9% | 7,601 | -1.1% | 0.01% | -10.0% |
Q4 2013 | $593,000 | +17.4% | 7,684 | +5.5% | 0.01% | 0.0% |
Q3 2013 | $505,000 | +27.8% | 7,284 | +16.7% | 0.01% | +11.1% |
Q2 2013 | $395,000 | – | 6,239 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |